Skip to main content

Table 1 Clinical characteristics for each study-group of subjects with insulin resistance and control group.

From: Circadian rhythm of the autonomic nervous system in insulin resistant subjects with normoglycemia, impaired fasting glycemia, impaired glucose tolerance, type 2 diabetes mellitus

 

NGT

IFG

IGT

DM

Controls

p (ANOVA)

Sex (M/F)

12/8

14/6

12/8

13/7

15/5

 

Age (years)

49,1 ± 6,6

49,8 ± 6,5

53,6 ± 3,7

52,4 ± 4,7

53,0 ± 8,0

NS

BMI (kg/m 2 )

27,3 ± 4,9

28,1 ± 4,7

26,2 ± 3,01

27,3 ± 2,8

25,0 ± 5,1

NS

WHR

0,97 ± 0,07

0,96 ± 0,04

0,98 ± 0,06

0,97 ± 0,05

0,9 ± 0,06

NS

Fasting plasma insulin (uU/ml)

19,3 ± 4,3

10,9 ± 2,9

12.67 ± 2.14

10.2 ± 2.9

7,1 ± 0,2

<0.001

HOMA-I

4,4 ± 0,8

3,1 ± 0,8

3,1 ± 0,6

2,7 ± 0,4

1,4 ± 0,2

 

HR

74,7 ± 4,5

76,6 ± 10,6

76,7 ± 10,9

75,0 ± 12,7

70,2 ± 4,1

NS

SBP (mmHg)

123,2 ± 3,7

121,1 ± 5,3

117,3 ± 11,2

121,0 ± 6,3

120,2 ± 7,0

NS

DBP(mmHg)

80,0 ± 3,1

78,1 ± 4,0

77,1 ± 6,7

77,7 ± 3,8

78,8 ± 4,9

NS

  1. Values are mean ± SD. P <0.05 was chosen to be the threshold of statistical significance for ANOVA. BMI: body mass index, HOMA-I: the homeostasis model assessment-index, WHR: waist to hip ratio, SBP: systolic blood pressure, DBP: diastolic blood pressure, HR: heart rate; NGR: normal glucose regulation, IFG: impaired fasting glycemia, IGT: impaired glucose tolerance, DM: type 2 diabetes.